Clinical Trial Update: Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia [Phase 2]

View source ↗

Summary

This Phase 2 study evaluated whether atorvastatin calcium, oligofructose-enriched inulin, or sulindac could prevent colorectal neoplasia in people at increased …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Neoplasia
• Colorectal Polyps
• Rectal Cancer

Drugs mentioned

• ATORVASTATIN CALCIUM (atorvastatin calcium)
• Oligofructose-enriched inulin (oligofructose-enriched inulin)
• Sulindac (sulindac)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colon Cancer, Precancerous Condition | Phase 2 | Status: COMPLETED | Results posted: 2013-02-08